Global Bio-chem Technology Group Co Ltd
OTC:GBCMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Global Bio-chem Technology Group Co Ltd
OTC:GBCMD
|
HK |
|
C
|
China Health Group Inc
F:VNL1
|
CN |
|
Seiko Epson Corp
F:SE7S
|
JP |
|
S
|
Spire Healthcare Group PLC
F:S00
|
UK |
Shareholder Yield
Current shareholder yield for GBCMD is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GBCMD Price
Global Bio-chem Technology Group Co Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -50% |
| Market Capitalization | 663.1m USD |
| Shares Outstanding | 16 788 210 000 |
| Percentage of Shares Shorted |
N/A
|
GBCMD Return Decomposition
Main factors of price return
Stock Splits
GBCMD's latest stock split occurred on Jun 26, 2026
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, GBCMD traded at 0.05 per share. Afterward, the share price was about 0.05.
The adjusted shares began trading on Jun 26, 2026. This was the only stock split in GBCMD's history.
